List of Tables
Table 1. Non-prescription Drugs Market Trends
Table 2. Non-prescription Drugs Market Drivers & Opportunity
Table 3. Non-prescription Drugs Market Challenges
Table 4. Non-prescription Drugs Market Restraints
Table 5. Global Non-prescription Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-prescription Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Non-prescription Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Non-prescription Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Non-prescription Drugs
Table 10. Global Non-prescription Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Non-prescription Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Non-prescription Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Non-prescription Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Non-prescription Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Non-prescription Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Non-prescription Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Non-prescription Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Non-prescription Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Non-prescription Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Non-prescription Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Non-prescription Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Non-prescription Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Non-prescription Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Non-prescription Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Non-prescription Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Non-prescription Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Non-prescription Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Non-prescription Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Non-prescription Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Non-prescription Drugs Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Roche Basic Information List
Table 37. Roche Description and Business Overview
Table 38. Roche Non-prescription Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Non-prescription Drugs Business of Roche (2019-2024)
Table 40. Roche Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi Non-prescription Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Non-prescription Drugs Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. Johnson & Johnson Basic Information List
Table 47. Johnson & Johnson Description and Business Overview
Table 48. Johnson & Johnson Non-prescription Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Non-prescription Drugs Business of Johnson & Johnson (2019-2024)
Table 50. Johnson & Johnson Recent Developments
Table 51. Merck & Co. (MSD) Basic Information List
Table 52. Merck & Co. (MSD) Description and Business Overview
Table 53. Merck & Co. (MSD) Non-prescription Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Non-prescription Drugs Business of Merck & Co. (MSD) (2019-2024)
Table 55. Merck & Co. (MSD) Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Non-prescription Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Non-prescription Drugs Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. AbbVie Basic Information List
Table 62. AbbVie Description and Business Overview
Table 63. AbbVie Non-prescription Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Non-prescription Drugs Business of AbbVie (2019-2024)
Table 65. AbbVie Recent Developments
Table 66. Gilead Sciences Basic Information List
Table 67. Gilead Sciences Description and Business Overview
Table 68. Gilead Sciences Non-prescription Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Non-prescription Drugs Business of Gilead Sciences (2019-2024)
Table 70. Gilead Sciences Recent Developments
Table 71. GlaxoSmithKline (GSK) Basic Information List
Table 72. GlaxoSmithKline (GSK) Description and Business Overview
Table 73. GlaxoSmithKline (GSK) Non-prescription Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Non-prescription Drugs Business of GlaxoSmithKline (GSK) (2019-2024)
Table 75. GlaxoSmithKline (GSK) Recent Developments
Table 76. Amgen Basic Information List
Table 77. Amgen Description and Business Overview
Table 78. Amgen Non-prescription Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Non-prescription Drugs Business of Amgen (2019-2024)
Table 80. Amgen Recent Developments
Table 81. AstraZeneca Basic Information List
Table 82. AstraZeneca Description and Business Overview
Table 83. AstraZeneca Non-prescription Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Non-prescription Drugs Business of AstraZeneca (2019-2024)
Table 85. AstraZeneca Recent Developments
Table 86. Bristol-Myers Squibb Basic Information List
Table 87. Bristol-Myers Squibb Description and Business Overview
Table 88. Bristol-Myers Squibb Non-prescription Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Non-prescription Drugs Business of Bristol-Myers Squibb (2019-2024)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Eli Lilly Basic Information List
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Non-prescription Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Non-prescription Drugs Business of Eli Lilly (2019-2024)
Table 95. Eli Lilly Recent Developments
Table 96. Teva Basic Information List
Table 97. Teva Description and Business Overview
Table 98. Teva Non-prescription Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Non-prescription Drugs Business of Teva (2019-2024)
Table 100. Teva Recent Developments
Table 101. Bayer Basic Information List
Table 102. Bayer Description and Business Overview
Table 103. Bayer Non-prescription Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Non-prescription Drugs Business of Bayer (2019-2024)
Table 105. Bayer Recent Developments
Table 106. Novo Nordisk Basic Information List
Table 107. Novo Nordisk Description and Business Overview
Table 108. Novo Nordisk Non-prescription Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Non-prescription Drugs Business of Novo Nordisk (2019-2024)
Table 110. Novo Nordisk Recent Developments
Table 111. AbbVie Basic Information List
Table 112. AbbVie Description and Business Overview
Table 113. AbbVie Non-prescription Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Non-prescription Drugs Business of AbbVie (2019-2024)
Table 115. AbbVie Recent Developments
Table 116. Takeda Basic Information List
Table 117. Takeda Description and Business Overview
Table 118. Takeda Non-prescription Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Non-prescription Drugs Business of Takeda (2019-2024)
Table 120. Takeda Recent Developments
Table 121. Boehringer Ingelheim Basic Information List
Table 122. Boehringer Ingelheim Description and Business Overview
Table 123. Boehringer Ingelheim Non-prescription Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Non-prescription Drugs Business of Boehringer Ingelheim (2019-2024)
Table 125. Boehringer Ingelheim Recent Developments
Table 126. Takeda Basic Information List
Table 127. Takeda Description and Business Overview
Table 128. Takeda Non-prescription Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Non-prescription Drugs Business of Takeda (2019-2024)
Table 130. Takeda Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Non-prescription Drugs Downstream Customers
Table 134. Non-prescription Drugs Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Non-prescription Drugs Product Picture
Figure 2. Global Non-prescription Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Non-prescription Drugs Report Years Considered
Figure 5. Global Non-prescription Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-prescription Drugs Revenue in 2023
Figure 7. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Brand Drugs Picture
Figure 9. Generic Drug Picture
Figure 10. Global Non-prescription Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Non-prescription Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Other
Figure 15. Global Non-prescription Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Non-prescription Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Non-prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Non-prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Non-prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Non-prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Non-prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Non-prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Non-prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Non-prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Non-prescription Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Non-prescription Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Non-prescription Drugs Sales Value (%), (2019-2030)
Figure 28. United States Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 34. China Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 36. China Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. India Non-prescription Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Non-prescription Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. India Non-prescription Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Non-prescription Drugs Industrial Chain
Figure 50. Non-prescription Drugs Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
